| 摘要 |
A pharmaceutical composition for the treatment of multidrug-resistant tuberculosis contains as active ingredients ethambutol hydrochloride and pyrazinamide, protionamid and lomefloxacine hydrochloride, and the components are used in the following ratio, wt.%:Pyrazinamide 0.1-48Ethambutol hydrochloride 0.1-18lomefloxacine hydrochloride 0.1-9.6Protionamid 0.1-24Auxiliary pharmaceutically suitablesubstances up to 100%and the pharmaceutical composition contains at least one layer with the active ingredient, suitable for slow release and ethambutol hydrochloride and protionamid. |
